IDO-1 Protein, Human (His)
Based on 1 Customer Validation
IDO proteins catalyze the first step in tryptophan catabolism via the kynurenine pathway, which is critical for immune tolerance and homeostasis maintenance. IDO-1 Protein, Human (His) is the recombinant human-derived IDO protein, expressed by E. coli , with N-6*His labeled tag.
- Species: Human
- Source: E. coli
-
Storage:Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
Biological Activity
Description
IDO proteins catalyze the first step in tryptophan catabolism via the kynurenine pathway, which is critical for immune tolerance and homeostasis maintenance. IDO-1 Protein, Human (His) is the recombinant human-derived IDO protein, expressed by E. coli , with N-6*His labeled tag.
Background
The IDO protein plays a central role in cellular processes by catalyzing the initial and rate-limiting step in the catabolism of the essential amino acid tryptophan along the kynurenine pathway, as documented in various studies. Beyond its enzymatic function, IDO is involved in peripheral immune tolerance, contributing to the maintenance of homeostasis by preventing autoimmunity or immunopathology resulting from uncontrolled and overreacting immune responses. Tryptophan scarcity, a consequence of IDO activity, inhibits T lymphocytes division, and the accumulation of tryptophan catabolites induces T-cell apoptosis while promoting the differentiation of regulatory T-cells. Additionally, IDO acts as a suppressor of anti-tumor immunity and limits the growth of intracellular pathogens by depriving them of tryptophan. Furthermore, IDO serves a crucial role in protecting the fetus from maternal immune rejection. These diverse functions underscore the significance of IDO in orchestrating immune responses, maintaining metabolic balance, and contributing to crucial physiological processes with implications for autoimmunity, cancer, and host-pathogen interactions.
Verified Bioactivity
Measured by its ability to oxidize L-tryptophan to N-formyl-kynurenine. The specific activity is 555.56-808.33 pmol/min/µg, as measured under the described conditions.
Technical Parameters
-
Species Human
-
Source E. coli
-
Tag N-6*His
-
Accession
P14902 (A2-G403)
-
Protein Length
Full Length
-
Synonyms
IDO1; Indoleamine-Pyrrole 2,3-Dioxygenase; Prev. INDO; Indolamine 2,3 Dioxygenase; Prev. IDO; Indole 2,3-Dioxygenase; IDO-1; Indoleamine 2,3-Dioxygenase 1; Indoleamine-Pyrrole 2,3 Dioxygenase
-
AA Sequence
AHAMENSWTISKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG
-
Molecular Weight
48 kDa
-
Purity
≥ 90%, as determined by reducing SDS-PAGE.
Product Properties
Solution
1.Supplied as a 0.22 μm filtered solution of 20 mM Sodium Acetate, 150 mM NaCl, 20% glycerol, pH 4.5.
2.Supplied as a 0.22 μm filtered solution of 50 mM Tris-HCl, 300 mM NaCl, pH 7.4, 20% glycerol.
Please refer to the lot-specific COA for specific buffer information.
Note: For SPR assay, please replace the buffer. Primary amine components (e.g., Tris, imidazole) can affect protein-coupled chips.
<1 EU/μg, determined by LAL method.
Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
Shipping with dry ice.
Documentation
-
Data Sheet (238 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)